Omnia Family Wealth’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12
Closed -$3K 146
2019
Q1
$3K Hold
12
﹤0.01% 370
2018
Q4
$4K Sell
12
-9
-43% -$2.87K ﹤0.01% 297
2018
Q3
$7K Hold
21
﹤0.01% 281
2018
Q2
$6K Buy
21
+10
+91% +$2.81K ﹤0.01% 288
2018
Q1
$3K Hold
11
﹤0.01% 353
2017
Q4
$4K Hold
11
﹤0.01% 345
2017
Q3
$3K Hold
11
﹤0.01% 379
2017
Q2
$3K Sell
11
-18
-62% -$4.76K ﹤0.01% 500
2017
Q1
$8K Sell
29
-10
-26% -$2.83K ﹤0.01% 308
2016
Q4
$11K Buy
+39
New +$11.6K 0.01% 274

Other funds holding BIIB

Omnia Family Wealth's BIIB Position: Q2 2019 in Review

Omnia Family Wealth sold out of Biogen (BIIB) in Q2 2019, closing a stake of 12 shares — an estimated $3K sold.

Omnia Family Wealth first reported a position in BIIB in Q4 2016 and held it in 10 quarters. The position peaked at $11K in Q4 2016. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Omnia Family Wealth reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Omnia Family Wealth sold 12 Biogen shares in Q2 2019, an estimated $3K.
  • Omnia Family Wealth first reported a position in Biogen in Q4 2016 and held it in 10 quarters.
  • Omnia Family Wealth's Biogen position peaked at $11K in Q4 2016.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.